The rate of major bleeding on apixaban in real-world registries ranges from 1.5% to 3.5% per patient-year, depending on patient age, renal function, and concomitant medications [15]
Many users inject it in abdominal fat for convenience regardless of injury location
At this concentration every 0.25 mg of dose is 0.1 mL, which is 10 units on a U-100 syringe
Link to the PDF with some thoughts below: fda.gov/media/193343/d The FDA reviewed 5 reports with 109 humans: 24 healthy volunteers rectal 53-person Ulcerative Colitis trial rectal 17 knee-pain patients intra-articular 12 bladder-pain patients intravesical 2 healthy volunteers IVThe FDA has 4 broad reasons against BPC: 1
It works behind the scenes to help neutralize free radicals, support cellular energy, and manage the daily stressors our modern environment places on us
Neurol Neuroimmunol Neuroinflamm (2017) 4(6):e399